Cardiac complications following mRNA COVID‐19 vaccines: A systematic review of case reports and case series

A Fazlollahi, M Zahmatyar, M Noori… - Reviews in medical …, 2022 - Wiley Online Library
There have been several local and systemic adverse events associated with mRNA COVID‐
19 vaccines. Pericarditis, myocarditis and myocardial infarction are examples of cardiac …

[HTML][HTML] Cardiovascular complications of SARS-CoV-2 vaccines: an overview

AA Shiravi, A Ardekani, E Sheikhbahaei… - Cardiology and …, 2022 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the deadly
disease known as coronavirus disease 2019 (COVID-19) that has reached pandemic …

Does COVID-19 cause hypertension?

M Akpek - Angiology, 2022 - journals.sagepub.com
The coronavirus disease 2019 (COVID-19) outbreak remains a major public health
challenge worldwide. The present study investigated the effect of COVID-19 on blood …

Cardiovascular adverse events reported from COVID-19 vaccines: a study based on WHO database

R Jeet Kaur, S Dutta, J Charan… - … journal of general …, 2021 - Taylor & Francis
Background Thirteen COVID-19 vaccines are granted emergency approval. It is crucial to
monitor their adverse events post vaccination. The present study focuses on cardiovascular …

[HTML][HTML] Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a …

S Sridhar, A Joaquin, MI Bonaparte… - The Lancet Infectious …, 2022 - thelancet.com
Background We evaluated our SARS-CoV-2 prefusion spike recombinant protein vaccine
(CoV2 preS dTM) with different adjuvants, unadjuvanted, and in a one-injection and two …

Cardiovascular and haematological events post COVID‐19 vaccination: A systematic review

D Al‐Ali, A Elshafeey, M Mushannen… - Journal of cellular …, 2022 - Wiley Online Library
Since COVID‐19 took a strong hold around the globe causing considerable morbidity and
mortality, a lot of effort was dedicated to manufacturing effective vaccines against SARS …

[HTML][HTML] Sex and gender in COVID-19 vaccine research: substantial evidence gaps remain

A Vassallo, S Shajahan, K Harris, L Hallam… - Frontiers in global …, 2021 - frontiersin.org
Since the start of the COVID-19 pandemic there has been a global call for sex/gender-
disaggregated data to be made available, which has uncovered important findings about …

[HTML][HTML] Blood pressure increase following COVID-19 vaccination: a systematic overview and meta-analysis

F Angeli, G Reboldi, M Trapasso, G Santilli… - Journal of …, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) vaccines proved a strong clinical efficacy against
symptomatic or moderate/severe COVID-19 and are considered the most promising …

[HTML][HTML] COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19

S Shibata, K Kobayashi, M Tanaka, K Asayama… - Hypertension …, 2023 - nature.com
The number of reported cases with coronavirus disease 2019 (COVID-19) has exceeded
620 million worldwide, still having a profound impact on people's health and daily lives since …

[HTML][HTML] Active surveillance of adverse events in healthcare workers recipients after vaccination with COVID-19 BNT162b2 vaccine (Pfizer-BioNTech, Comirnaty): a …

G Ripabelli, M Tamburro, N Buccieri, C Adesso… - Journal of Community …, 2022 - Springer
In this cross-sectional study, adverse events after the first and second dose of BNT162b2
mRNA (Pfizer-BioNTech, Comirnaty) vaccine against coronavirus disease 2019 were …